These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7312923)

  • 1. Influence of high fat diet on GI absorption of griseofulvin tablets in man.
    Khalafalla N; Elgholmy ZA; Khalil SA
    Pharmazie; 1981 Oct; 36(10):692-3. PubMed ID: 7312923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of different brands of griseofulvin tablets and its correlation to dissolution data.
    Khalafalla N; Elgholmy ZA; Khalil SA
    Pharmazie; 1980 Aug; 35(8):482-4. PubMed ID: 7433499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal absorption of griseofulvin from corn oil-in-water emulsions: effect of amount of corn oil ingested in man.
    Bates TR; Pieniaszek HJ; Sequeira JA; Rasmussen JE
    Arch Dermatol; 1977 Mar; 113(3):302-6. PubMed ID: 843096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fat contents of meals and bioavailability of griseofulvin in man.
    Ogunbona FA; Smith IF; Olawoye OS
    J Pharm Pharmacol; 1985 Apr; 37(4):283-4. PubMed ID: 2860234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: a single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states.
    Ahmed IS; Aboul-Einien MH; Mohamed OH; Farid SF
    Eur J Pharm Sci; 2008 Oct; 35(3):219-25. PubMed ID: 18675344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
    Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative bioavailability of anhydrous griseofulvin and its chloroform solvate in man.
    Bates TR; Fung HL; Lee H; Tembo AV
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):233-43. PubMed ID: 1153870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parameters affecting absorption of griseofulvin in a human subject using urinary metabolite excretion data.
    Kabasakalian P; Katz M; Rosenkrantz B; Townley E
    J Pharm Sci; 1970 May; 59(5):595-600. PubMed ID: 5446411
    [No Abstract]   [Full Text] [Related]  

  • 9. The in vitro liberation and the bioavailability of different brands of griseofulvin in plasma and urine in man.
    Terhaag B; Le Petit G; Pachaly C; Feller K
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):475-9. PubMed ID: 4055158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption characteristics of solid dispersed and micronized griseofulvin in man.
    Chiou WL; Riegelman S
    J Pharm Sci; 1971 Sep; 60(9):1376-80. PubMed ID: 5567588
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans.
    Tubic M; Wagner D; Spahn-Langguth H; Weiler C; Wanitschke R; Böcher WO; Langguth P
    Eur J Pharm Sci; 2006 Nov; 29(3-4):231-9. PubMed ID: 16713700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bioavailability of griseofulvin PEG ultramicrosize (Gris-PEG) tablets in man under steady-state conditions.
    Barrett WE; Hanigan JJ
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):491-500. PubMed ID: 810309
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin.
    Ahmed IS; Aboul-Einien MH
    Eur J Pharm Sci; 2007 Sep; 32(1):58-68. PubMed ID: 17628451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised four-intervention crossover study investigating the effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and triacylglycerols in middle-aged men.
    Brynes AE; Mark Edwards C; Ghatei MA; Dornhorst A; Morgan LM; Bloom SR; Frost GS
    Br J Nutr; 2003 Feb; 89(2):207-18. PubMed ID: 12575905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.
    Guivarc'h PH; Vachon MG; Fordyce D
    Clin Ther; 2004 Sep; 26(9):1456-69. PubMed ID: 15531008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bioavailability of ultramicrosize griseofulvin (Gris-PEG) tablets in man.
    Barrett WE; Bianchine JR
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):501-9. PubMed ID: 810310
    [No Abstract]   [Full Text] [Related]  

  • 17. Absorption, metabolism and excretion of 14C-griseofulvin in man.
    Lin CC; Magat J; Chang R; McGlotten J; Symchowicz S
    J Pharmacol Exp Ther; 1973 Nov; 187(2):415-22. PubMed ID: 4748557
    [No Abstract]   [Full Text] [Related]  

  • 18. Larger griseofulvin tablets.
    Drug Ther Bull; 1969 Oct; 7(22):88. PubMed ID: 5345002
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of rabbits for GI drug absorption studies: relationship between dissolution rate and bioavailability of griseofulvin tablets.
    Maeda T; Takenaka H; Yamahira Y; Noguchi T
    J Pharm Sci; 1979 Oct; 68(10):1286-9. PubMed ID: 512862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of low-fat milk and fermented low-fat milk on cholesterol absorption and excretion in ileostomy subjects.
    Andersson H; Bosaeus I; Ellegård L; Grahn E; Tidehag P; Hallmans G; Holm S; Sandberg AS
    Eur J Clin Nutr; 1995 Apr; 49(4):274-81. PubMed ID: 7796785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.